Traws Pharma, Inc. — Director's Dealing 2016

Sep 1, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2016-09-01

Reporting Person: Kumar Ramesh (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-01	Stock Option (right to purchase)	$3.24	A	44000	Acquired	2026-09-01	Common Stock (44000)	Direct

Footnotes

F1: These options vest over three years in 36 equal monthly installments.